Cargando…
Pharmacological treatment of bipolar disorder in pregnancy: An update on safety considerations
Pregnancy in women with bipolar disorder (BD) can be considered a high-risk pregnancy in view of several clinical and pharmacotherapeutic considerations. Pharmacological treatment during pregnancy requires a careful weighing of psychotropic drug exposure against the risk of BD relapse. An untreated...
Autores principales: | Singh, Swarndeep, Deep, Raman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043818/ https://www.ncbi.nlm.nih.gov/pubmed/36722556 http://dx.doi.org/10.4103/ijp.ijp_407_21 |
Ejemplares similares
-
Screening for lifetime bipolarity in women with perinatal depression: Need for clinical and research attention
por: Singh, Swarndeep, et al.
Publicado: (2022) -
Assessment of lithium-related knowledge and attitudes among patients with bipolar disorder on long-term lithium maintenance treatment
por: Kumar, Saurabh, et al.
Publicado: (2020) -
Potential biomarkers for bipolar disorder: Where do we stand?
por: Sagar, Rajesh, et al.
Publicado: (2017) -
Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges
por: Epstein, Richard A, et al.
Publicado: (2014) -
A History of the Pharmacological Treatment of Bipolar Disorder
por: López-Muñoz, Francisco, et al.
Publicado: (2018)